FDA Inspection 898126 — Nanjing White Whale Pharmaceutical Co., Ltd.
The FDA completed an inspection of Nanjing White Whale Pharmaceutical Co., Ltd. on September 19, 2014 in Nanjing. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 19, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Nanjing (China)